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Abstract
We conducted a genome-wide association study meta-analysis of mean arterial pressure and pulse
pressure among 26,600 East Asian participants (stage-1) followed by replication study of up to
28,783 participants (stage-2). For novel loci, statistical significance was determined by a
P<5.0×10−8 in joint analysis of stage-1 and stage-2 data. For loci reported by the previous mean
arterial and pulse pressure genome-wide association study meta-analysis in Europeans, evidence
of trans-ethnic replication was determined by consistency in effect direction and a Bonferroni-
corrected P<1.4×10−3. No novel loci were identified by the current study. Five independent mean
arterial pressure variants demonstrated robust evidence for trans-ethnic replication including
rs17249754 at ATP2B1 (P=7.5×10−15), rs2681492 at ATP2B1 (P=3.4×10−7), rs11191593 at
NT5C2 (1.1×10−6), rs3824755 at CYP17A1 (P=1.2×10−6), and rs13149993 at FGF5
(P=2.4×10−4). Two additional variants showed suggestive evidence of trans-ethnic replication
(consistency in effect direction and P<0.05), including rs319690 at MAP4 (P=0.014) and
rs1173771 at NPR3 (P=0.018). For pulse pressure, robust evidence of replication was identified
for 2 independent variants, including rs17249754 at ATP2B1 (P=1.2×10−5) and rs11191593 at
NT5C2 (P=1.1×10−3), with suggestive evidence of replication among an additional 2 variants
including rs3824755 at CYP17A1 (P=6.1×10−3) and rs2681492 at ATP2B1 (P=9.0×10−3).
Replicated variants demonstrated consistency in effect sizes between East Asian and European
samples, with effect size differences ranging from 0.03 to 0.24 mmHg for mean arterial pressure
and from 0.03 to 0.21 mmHg for pulse pressure. In conclusion, we present the first evidence of
trans-ethnic replication of several mean arterial and pulse pressure loci in an East Asian
population.
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Hypertension affects nearly 30% of the world’s adult population and has been identified as
the leading risk factor for mortality globally1–3. A common complex trait, high blood
pressure (BP) is influenced by genomic and environmental factors, as well as their
interactions4–7. Recent genome-wide association study (GWAS) meta-analyses have made
important strides in advancing hypertension genomic research through the identification of
numerous novel loci for systolic blood pressure (SBP) and diastolic blood pressure
(DBP)4–7. Mean arterial pressure (MAP), defined as the average pressure in the arteries, and
pulse pressure (PP), a measure of large artery stiffness, represent two additional blood
pressure components which also predict cardiovascular disease risk and mortality8–11.
Despite their public health relevance and established heritability12–14, only one previous
GWAS meta-analysis has reported genomic loci influencing these traits15. Wain and
colleagues described several novel MAP and PP loci which they identified exclusively in
populations of European descent15. GWAS meta-analyses in distinct ethnic groups could
enable the discovery of additional novel loci for MAP and PP and help to determine whether
the previously reported variants are relevant to populations of non-European ancestry.
We carried out the first ever GWAS meta-analysis of MAP and PP in East Asian
participants to: 1) identify novel loci influencing MAP and PP; and 2) determine whether
loci previously identified in populations of European ancestry could be replicated among a
distinct ethnic group. Here we report the results of our two-stage study that included a meta-




The Asian Genetic Epidemiology Network (AGEN)-MAP/PP work-group consists of 9
GWAS conducted in East Asian populations. Each AGEN-MAP/PP study collected at least
2 measurements of systolic blood pressure (SBP) and diastolic blood pressure (DBP) in a
clinical setting using methods described previously 6. If participants were taking
antihypertension medications, 10 mmHg and 5 mmHg were added to measured SBP and
DBP, respectively. Mean MAP and PP were calculated for each participant from SBP and
DBP values. Prior to GWAS, each study imputed the HapMap set of approximately 2.4
million single nucleotide polymorphisms (SNPs)16–18. GWAS of MAP and PP in each study
were carried out using linear regression models to adjust for age, age2, gender, body mass
index, and enrollment site (for multi-site studies). Detailed study-specific information can be
found in Table 1, the Supplementary Note, and Table S1.
Inverse-variance weighted fixed effect meta-analyses of MAP and PP results from the 9
GWAS were carried out using METAL19. SNPs were excluded if they had minor allele
frequency (MAF)<0.05, Hardy-Weinberg P<1×10−6, call rate<0.95, imputation quality
score<0.5, sample size less than 10,000 or showed evidence of heterogeneity across studies
(P for Cochrane’s Q-test<1×10−6). Genomic control was applied to each study (Table S1)
and the final meta-analyses (λGC=1.02 for MAP and λGC=1.00 for PP; and Figure S1).
Stage-2 replication studies and joint analyses
Novel SNPs were selected for stage-2 replication genotyping by choosing the most
significant SNP from loci which achieved a stage-1 P<1.0×10−5 for MAP or PP. We
considered physiological plausibility by also selecting SNPs located within candidate
genes20 if they achieved P<1.0×10−4 for either MAP or PP or P<1.0×10−3 for both MAP
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and PP. For assessment of trans-ethnic replication, previously identified MAP and PP
SNPs15 which achieved nominal significance (P<0.05) in stage-1 study were selected for
evaluation in the in-silico replication stage.
In-silico or de novo replication genotyping and association analyses were conducted in up to
six additional samples of 28,783 participants (Table 1, Supplementary Note). Meta-analysis
was again used to combine results across the stage-2 studies and to conduct joint analysis of
stage-1 and stage-2 findings. For novel loci, findings were considered significant if they
achieved genome-wide significance (P<5.0×10−8) in the joint analysis. For loci previously
identified in European populations, a Bonferroni P<1.35×10−3 and consistency in effect
direction was considered evidence of replication.
RESULTS
In the stage-1 GWAS meta-analysis of 26,600 participants, genome-wide significance was
achieved at 12q21.33 (rs17249754) at the widely reported ATP2B1 locus for the MAP
phenotype (P=3.65×10−12; Figure 1 and Table 2). For PP, novel loci TCL6 at 14q32.13
(rs2145975; P=1.90×10−8) and TTC39C at 18q11.2 (rs11874765; P=3.14×10−8) achieved
genome-wide significance in stage-1 study (Figure 1 and Table S2). Six additional novel
MAP and PP loci achieved borderline significance (P<1.0×10−6; Figure 1 and Table S2). A
full list of stage-1 P-values for the associations between each of the 2.4 million SNPs and
the MAP and PP phenotypes are publicly available for download at
www.agenconsortium.org/publications.php.
A total of 35 independent, novel trait-associated SNPs were selected for stage-2 replication
study. None achieved genome-wide significance in joint analysis of stage-1 and stage-2
findings (Table S2). Among 48 SNPs which previously achieved genome-wide significance
for MAP or PP traits in European populations15, 11 independent loci achieved nominal
significance in the stage-1 study and were followed-up in stage-2 study (Table S3).
Table 2 provides top trans-ethnic replication results. For the MAP phenotype, rs17249754 at
ATP2B1 achieved genome-wide significance in the joint analysis of stage-1 and stage-2
studies (P=7.48×10−15). Four additional SNPs showed robust evidence of replication for
MAP (consistency of effect direction and significance after adjustment for multiple testing),
including rs13149993 at FGF5 (P=2.39×10−4), rs3824755 at CYP17A1 (P=1.21×10−6),
rs11191593 at NT5C2 (1.13×10−6), and rs2681492 at ATP2B1 (P=3.39×10−7). Furthermore,
two SNPs showed suggestive replication [consistency of effect direction and nominal
significance (P<0.05)], including rs319690 at MAP4 (P=0.01) and rs1173771 at NPR3
(P=0.02). For the PP phenotype, robust evidence of replication was identified for 2 SNPs
including rs11191593 at NT5C2 (P=1.14×10−3) and rs17249754 at ATP2B1 (P=1.21×10−5).
Suggestive evidence of replication was identified for 2 additional SNPs including rs3824755
at CYP17A1 (P=6.12×10−3) and rs2681492 at ATP2B1 (P=9.02×10−3). Effect sizes of
replicated MAP and PP loci were very similar between the previous GWAS meta-analysis of
Europeans15 and the current GWAS meta-analysis of East Asians (Figure 2).
DISCUSSION
The current meta-analysis of 26,600 East Asian participants provided robust trans-ethnic
replication evidence for 5 independent SNPs at MAP and PP loci previously identified in
populations of European ancestry15, including rs13149993 at FGF5, rs3824755 at
CYP17A1, rs11191593 at NT5C2, rs2681492 at ATP2B1, and rs17249754 at ATP2B1. In
addition, two SNPs, rs319690 at MAP4 and rs1173771 at NPR3, showed suggestive
evidence of trans-ethnic replication. Further examination of these 7 variants demonstrated
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remarkable consistency in per allele effect sizes across populations of East Asian and
European ancestry.
Seven SNPs from MAP and PP loci identified in samples of European ancestry showed
evidence of trans-ethnic replication in the current study of East Asians. Marker rs17249754
at the ATP2B1 locus (12q21.33) achieved genome-wide significance for MAP and was
robustly associated with PP. Furthermore, rs2681492, a moderately correlated intronic
ATP2B1 SNP (r2=0.78), also showed evidence of trans-ethnic replication for the MAP and
PP phenotypes. ATP2B1 is a widely reported BP-related gene, with marker rs17249754 also
identified for the SBP and DBP phenotypes in East Asians4–7, 15. ATP2B1 is thought to
exert its influence on BP regulation through alteration of calcium handling and
vasoconstriction in vascular smooth muscle cells21. At 3p21.31, the current study provided
the first evidence of association for marker rs319690 with a BP-related phenotype among
individuals with East Asian ancestry. Marker rs319690 represents an intronic variant of the
MAP4 gene, implicated in heart failure through its interference with beta-adrenergic receptor
recycling22. At the FGF5 locus (4q21.21), marker rs13149993 was associated with both
MAP and PP phenotypes in the current study. The FGF5 rs13149993 variant [or a proxy
(r2>0.8)] has been reported previously for its associations with not only MAP but other BP-
related phenotypes5,7,15. Furthermore, a variant modestly correlated with rs13149993 at
FGF5, rs16998073 (r2=0.49), was previously related to SBP and DBP in East Asians6,23. A
fibroblast growth factor gene, FGF5 is expressed in cardiac myocytes and has been shown
to promote angiogenesis in the heart24. Near NPR3 (at 5p13.3), rs1173771 was associated
with MAP in the current study. Previously reported for its association with MAP in
Caucasians and other BP phenotypes in Caucasians and East Asians6,7,15, NPR3 encodes the
natriuretic peptide receptor C, a peptide known to regulate BP and fluid homeostasis by
modifying glomerular filtration rate and sodium urinary excretion25. Finally, moderately
correlated SNPs rs3824755 and rs11191593 (r2=0.67) at 10q24.32-10q24.33 were associated
with MAP and PP in the current study. Marker rs3824755 is an intronic variant of CYP17A1,
the gene responsible for the monogenic BP disorder congenital adrenal hyperplasia26, while
rs11191593 is an intronic variant of NT5C2, a gene involved in DNA synthesis with no
known functional role in BP regulation27. Marker rs3824755 (or a proxy) was previously
reported to associate with not only MAP and PP15 but also SBP in the manuscript by Levy
and colleagues4, while rs11191593 (or a proxy) has been reported previously for numerous
BP phenotypes, including SBP and DBP in East Asians5–7, 15.
The current GWAS meta-analysis represents the largest genetic association study of MAP
and PP conducted in participants of East Asians ancestry to date. Additional study strengths
include the adherence of all studies to a standard analytic protocol and stringent genotyping
and imputation quality control procedures at the study and meta-analysis levels. Despite
these strengths, the current study failed to identify any novel loci related to MAP and PP
traits. Although currently the largest study conducted in East Asians, the stage-1 sample was
only one-third the size of that of the prior GWAS meta-analysis of MAP and PP conducted
in populations of European ancestry15. Thus, we still may have lacked the statistical power
needed to identify novel variants for MAP and PP. Furthermore, we did not replicate 24 of
the 31 loci previously identified in Europeans. Lack of replication could be related to
differences in linkage disequilibrium (LD) patterns between Europeans and East Asians. To
address this concern, we examined inter-population LD variation at these loci28. Our results
showed that LD structure was generally similar between populations at all but five regions
(see Figure S2). However, examination of variants in LD with the lead SNP in Europeans
did not reveal any further significant associations in East Asians, suggesting that differences
in LD may not have been a major factor limiting replication in the current study (data not
shown). Lack of replication could also be due to limited statistical power. To assess this
issue, we compared effect sizes and MAFs of independent SNPs which achieved genome-
Kelly et al. Page 4













wide significance in Europeans between the two studies (Table S4). Despite differences in
the MAF of many of the variants, very strong correlations in effect sizes between
populations were observed (Table S4). Furthermore, power calculations demonstrated that
we lacked the statistical power to detect associations for the 24 un-replicated loci (Table S5).
These data suggest the existence of additional promising MAP and PP loci in East Asian
populations that may be identified by future, larger GWAS meta-analyses.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The current study of 26,600 East Asian participants from 9 GWAS provides the first
evidence of trans-ethnic replication of 7 MAP and PP loci previously identified in
populations of European ancestry. In addition, we demonstrate remarkable consistency in
allelic effect sizes between populations with vast differences in not only genomic
ancestry but also environmental and cultural factors. Our findings add to the
accumulating evidence that many genomic associations are reproducible in populations
with distinct LD structure, suggesting common genomic mechanisms underlying the
development of hypertension and cardiovascular disease across populations.
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• The current GWAS meta-analysis of 26,600 East Asians the first evidence of
trans-ethnic replication of 7 MAP and PP loci previously identified in
populations of European ancestry.
• Per allele effect sizes of replicated variants were consistent between Europeans
and East Asians.
What is Relevant?
• The physiologic effects of many common polymorphisms may be generalizable
across populations.
Summary
The current meta-analysis of 26,600 East Asian participants from 9 GWAS provided
evidence of trans-ethnic replication for 7 MAP and PP variants previously identified in
populations of European ancestry15. These variants demonstrated remarkable consistency
in per allele effect sizes across populations of East Asian and European ancestry. We add
to the accumulating evidence that many genomic associations are reproducible in
populations with distinct linkage disequilibrium structure, suggesting common genomic
mechanisms underlying the development of hypertension and cardiovascular disease
across populations.
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Genome-wide association study (GWAS) meta-analysis results for MAP (a) and PP (b).
Loci highlighted in red indicate the 2 Mb regions of SNPs which achieved genome-wide
significance in stage-1 and joint analyses of stage-1 and stage-2 studies. Loci highlighted in
black indicate the 2 Mb regions of SNPs which achieved borderline significance (P<1E-6) in
the stage-1 GWAS meta-analysis. Loci highlighted in blue indicate the 2 Mb regions of
SNPs which achieved genome-wide significance in the GWAS meta-analysis of Europeans
(unless achieving P<1E-6 in the current study)15. Loci which achieved genome-wide
significance in Europeans15 or East Asians are labeled (blue if originally identified in
Europeans; black if originally identified in the current study).
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Effect sizes and coded allele frequencies (CAF) for SNPs that showed evidence of trans-
ethnic replication for MAP (a) and PP (b) in East Asian participants of the current GWAS
meta-analysis. Effect sizes in the current study of East Asians are shown in black while
those of the previous GWAS meta-analysis of Europeans15 are shown in red.
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